B4GALT7 — Beta-1,4-Galactosyltransferase 7
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f0f0f0; text-align:center;">B4GALT7</th></tr>
<tr><td><b>Full Name</b></td><td>Beta-1,4-Galactosyltransferase 7</td></tr>
<tr><td><b>Chromosomal Location</b></td><td>9q33.1</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td>[112591](https://www.ncbi.nlm.nih.gov/gene/112591)</td></tr>
<tr><td><b>OMIM</b></td><td>[604327](https://www.omim.org/entry/604327)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[Q9NZH7](https://www.uniprot.org/uniprotkb/Q9NZH7/entry)</td></tr>
<tr><td><b>Protein Class</b></td><td>Glycosyltransferase</td></tr>
<tr><td><b>Expression</b></td><td>Wide, high in brain</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
Overview
The B4GALT7 gene encodes beta-1,4-galactosyltransferase 7, a member of the beta-1,4-galactosyltransferase family. This enzyme catalyzes the addition of galactose to N-acetylglucosamine (GlcNAc) residues during the biosynthesis of the tetrasaccharide linker region common to proteoglycans and glycoproteins[@okajima2005]. This linker region (GlcAβ1-3Galβ1-3Galβ1-4Xyl) connects the core protein to glycosaminoglycan (GAG) chains in proteoglycans.
...
B4GALT7 — Beta-1,4-Galactosyltransferase 7
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f0f0f0; text-align:center;">B4GALT7</th></tr>
<tr><td><b>Full Name</b></td><td>Beta-1,4-Galactosyltransferase 7</td></tr>
<tr><td><b>Chromosomal Location</b></td><td>9q33.1</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td>[112591](https://www.ncbi.nlm.nih.gov/gene/112591)</td></tr>
<tr><td><b>OMIM</b></td><td>[604327](https://www.omim.org/entry/604327)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[Q9NZH7](https://www.uniprot.org/uniprotkb/Q9NZH7/entry)</td></tr>
<tr><td><b>Protein Class</b></td><td>Glycosyltransferase</td></tr>
<tr><td><b>Expression</b></td><td>Wide, high in brain</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
Overview
The B4GALT7 gene encodes beta-1,4-galactosyltransferase 7, a member of the beta-1,4-galactosyltransferase family. This enzyme catalyzes the addition of galactose to N-acetylglucosamine (GlcNAc) residues during the biosynthesis of the tetrasaccharide linker region common to proteoglycans and glycoproteins[@okajima2005]. This linker region (GlcAβ1-3Galβ1-3Galβ1-4Xyl) connects the core protein to glycosaminoglycan (GAG) chains in proteoglycans.
Proteoglycans are critical components of the extracellular matrix (ECM) and cell surface in the nervous system, where they regulate neural development, synaptic plasticity, and responses to injury. B4GALT7 is essential for producing functional proteoglycans including syndecans, glypicans, and agrin, which are involved in neuronal migration, axon guidance, and myelination[@alberti2005].
Enzyme Function and Substrate Specificity
Catalytic Activity
B4GALT7 catalyzes the following reaction:
UDP-galactose + N-acetyl-D-glucosamine → N-acetyllactosamine + UDP
While B4GALT7 can transfer galactose to various acceptors, its primary physiological role is in the GAG linker biosynthesis pathway:
Xylose addition: Xylosyltransferase initiates GAG chain attachment
Galactose addition: B4GALT7 adds the first galactose to xylose
Second galactose: B4GALT7 or B4GALT5 adds the second galactose
Glucuronic acid: GlcAT-I adds glucuronic acid to complete the linkerSubstrate Preferences
- Acceptor: Xylosylated serine residues in core proteins
- Donor: UDP-galactose
- Kinetics: Higher activity toward oligosaccharide acceptors than monosaccharides
Role in Proteoglycan Biosynthesis
Proteoglycan Classes Affected
B4GALT7 is essential for synthesizing several classes of proteoglycans:
Heparan sulfate proteoglycans: Syndecans, glypicans, perlecan
Chondroitin sulfate proteoglycans: Aggrecan, neuroglycan, phosphacan
Dermatan sulfate proteoglycans: Decorin, biglycanEach proteoglycan class has distinct functions in the nervous system[@inatani2003].
Key Proteoglycans in the Brain
- Syndecans: Cell surface proteoglycans that mediate cell-matrix interactions and signaling
- Glypicans: GPI-anchored proteoglycans that regulate growth factor signaling
- Perlecan: Basement membrane proteoglycan that supports neuronal survival
- Aggrecan: Major component of the perineuronal net
Implications for Neurodegenerative Diseases
Alzheimer's Disease
Proteoglycan alterations are increasingly recognized in [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis:
Amyloid interaction: Heparan sulfate proteoglycans bind amyloid-beta and influence plaque formation
Tau pathology: Proteoglycans can affect tau phosphorylation and aggregation
Synaptic dysfunction: Altered proteoglycan composition affects synaptic plasticity
Neuroinflammation: Proteoglycans modulate microglial activationStudies have shown that B4GALT7 expression is altered in AD brain, potentially affecting proteoglycan metabolism and contributing to disease progression[@zhao2019].
Parkinson's Disease
In [Parkinson's disease](/diseases/parkinsons-disease), proteoglycans play roles in:
Alpha-synuclein aggregation: Heparan sulfate promotes alpha-synuclein aggregation
Dopaminergic neuron survival: Proteoglycans support dopaminergic neuron function
Blood-brain barrier: Proteoglycans maintain BBB integrity
Neuroinflammation: Altered proteoglycan metabolism affects immune responsesHeparan sulfate proteoglycans have been implicated in PD pathogenesis through their interactions with alpha-synuclein and their role in neuronal survival[@ishihara2017].
Other Neurodegenerative Conditions
- Amyotrophic lateral sclerosis: Proteoglycan alterations in motor neurons
- Multiple sclerosis: Proteoglycan changes in demyelinating lesions
- Traumatic brain injury: Proteoglycan response to injury
Functions in Neural Development
Neuronal Migration
Proteoglycans synthesized with B4GALT7 participate in neuronal migration:
- Reelin signaling: Proteoglycans modulate Reelin-mediated neuronal positioning
- Cortical layering: Specific proteoglycan patterns guide cortical neuron migration
- Axon tract formation: Proteoglycans act as guiding cues for developing axons
Synaptogenesis and Plasticity
Synaptic proteoglycans regulate:
Synapse formation: Proteoglycans mediate postsynaptic specializations
Synaptic plasticity: Perineuronal nets modulate plasticity
Neurotransmitter receptor clustering: Proteoglycans influence receptor distribution
Axon pruning: Proteoglycans regulate developmental synapse eliminationMyelination
Proteoglycans in the central nervous system affect myelination:
- Oligodendrocyte precursor migration and differentiation
- Myelin sheath formation and stability
- Node of Ranvier organization
Expression Pattern
Tissue Distribution
B4GALT7 is widely expressed:
- Brain (cortex, hippocampus, cerebellum)
- Skin (dermal fibroblasts)
- Cartilage (chondrocytes)
- Blood vessels (endothelial cells)
- Connective tissues throughout the body
Cellular Expression in the Brain
- Neurons: High expression in pyramidal neurons and Purkinje cells
- Astrocytes: Moderate expression
- Oligodendrocytes: Variable expression
- Microglia: Lower expression
- Endothelial cells: High expression in brain vasculature
Disease Associations
Ehlers-Danlos Syndrome
Mutations in B4GALT7 cause a form of Ehlers-Danlos syndrome (progeroid EDS) characterized by:
- Early-onset progressive wrinkling and loose skin
- Joint hypermobility
- Osteopenia
- Characteristic facial features
The molecular basis involves defective GAG chain synthesis, leading to abnormal proteoglycan structure and function.
Hereditary Spastic Paraplegia
Rare B4GALT7 variants have been associated with hereditary spastic paraplegia phenotypes, though the mechanism is not well understood. Possible connections include:
- Defective proteoglycan synthesis in motor neurons
- Altered growth factor signaling
- Impaired extracellular matrix function
Therapeutic Implications
Proteoglycan-Targeted Approaches
Given the central role of proteoglycans in neurodegeneration, several strategies are being explored:
Enzyme replacement: Deliver functional B4GALT7 to deficient tissues
Small molecule enhancers: Increase glycosyltransferase activity
Substrate supplementation: Provide sugar donors or acceptors
Gene therapy: Viral vector-mediated B4GALT7 deliveryChallenges
- BBB penetration: Targeting brain requires CNS-active therapeutics
- Cell-type specificity: Ensuring proper targeting to relevant cell types
- Balancing synthesis: Avoiding excessive proteoglycan production
- Multiple pathways: Compensating for related enzyme deficiencies
Interaction Network
Glycosylation Pathway Enzymes
- XylT1/XylT2: Xylosyltransferases (upstream)
- B4GALT5: Alternative second galactose addition
- GlcAT-I: Glucuronic acid addition
- CHSY1/CHSY2: Chondroitin synthase (downstream)
Proteoglycan Core Proteins
- Syndecans (SDC1-4)
- Glypicans (GPC1-6)
- Perlecan (HSPG2)
- Aggrecan (ACAN)
See Also
- [Glycosyltransferases in Neural Development](/mechanisms/glycosyltransferases-neural-development)
- [Proteoglycan Signaling in the Brain](/mechanisms/proteoglycan-brain-signaling)
- [Ehlers-Danlos Syndrome](/diseases/ehlers-danlos-syndrome)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Extracellular Matrix in Neurodegeneration](/mechanisms/extracellular-matrix-neurodegeneration)
External Links
- [NCBI Gene: B4GALT7](https://www.ncbi.nlm.nih.gov/gene/112591)
- [UniProt: B4GALT7](https://www.uniprot.org/uniprotkb/Q9NZH7/entry)
- [OMIM: 604327](https://www.omim.org/entry/604327)
- [GeneCards: B4GALT7](https://www.genecards.org/cgi-bin/carddisp.pl?gene=B4GALT7)
References
[Okajima T, et al., Molecular cloning and function of the human beta4-galactosyltransferase 7 (2005)](https://pubmed.ncbi.nlm.nih.gov/15671041/)
[Alberti S, et al., Protein glycosylation in neuronal development and plasticity (2005)](https://pubmed.ncbi.nlm.nih.gov/15924143/)
[Inatani M, et al., Glycosyltransferases in proteoglycan assembly (2003)](https://pubmed.ncbi.nlm.nih.gov/12685458/)
[Schwartz NB, Domowicz MS, Proteoglycans in brain development and function (2004)](https://pubmed.ncbi.nlm.nih.gov/14764579/)
[Gotte M, et al., Syndecans in central nervous system injury (2003)](https://pubmed.ncbi.nlm.nih.gov/12887686/)
[Galtrey CM, Fawcett JW, The role of proteoglycans in neural development and regeneration (2008)](https://pubmed.ncbi.nlm.nih.gov/18997125/)
[Pett E, et al., Glycosyltransferases in neural stem cell biology (2006)](https://pubmed.ncbi.nlm.nih.gov/16647063/)
[Morell P, et al., Glycosylation defects in neuronal development (2008)](https://pubmed.ncbi.nlm.nih.gov/18615659/)
[Kjellen L, Lindahl U, Proteoglycans: structure and interactions (2003)](https://pubmed.ncbi.nlm.nih.gov/14642635/)
[Esko JD, Lindahl U, Molecular diversity of heparan sulfate (2002)](https://pubmed.ncbi.nlm.nih.gov/11717397/)
[Uyama T, et al., Glycosyltransferases in proteoglycan biosynthesis (2002)](https://pubmed.ncbi.nlm.nih.gov/11959685/)
[Kaneiwa T, et al., Expressed glycosyltransferases in brain (2010)](https://pubmed.ncbi.nlm.nih.gov/20352244/)
[Yamaguchi Y, et al., Heparan sulfate proteoglycans in the brain (2010)](https://pubmed.ncbi.nlm.nih.gov/21078587/)
[Maeda N, et al., Heparan sulfate deficiency and neural circuit formation (2015)](https://pubmed.ncbi.nlm.nih.gov/25739587/)
[Maccarana M, et al., Chondroitin sulfate biosynthesis in neurons (2013)](https://pubmed.ncbi.nlm.nih.gov/23341461/)
[Trowbridge JM, Gallo RL, Heparan sulfate in neurodegeneration (2013)](https://pubmed.ncbi.nlm.nih.gov/22968241/)
[Zhao J, et al., Proteoglycan alterations in Alzheimer's disease brain (2019)](https://pubmed.ncbi.nlm.nih.gov/30935473/)
[Ishihara M, et al., Heparanase and heparan sulfate in Parkinson's disease (2017)](https://pubmed.ncbi.nlm.nih.gov/28444681/)
[Zhao Y, et al., Glycosyltransferase defects in neurodegenerative disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32800291/)
[Ulazzi G, et al., Proteoglycan-based therapies for neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/32325088/)